Evidence map›Paper›PMID 36471041›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2023

Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson's Disease (PD) and dementia with Lewy bodies (DLB).

Francesco Lanfranchi, Dario Arnaldi, Alberto Miceli, Pietro Mattioli, Francesca D'Amico, Stefano Raffa, Maria Isabella Donegani, Silvia Chiola, Federico Massa, Matteo Pardini and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. [Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Effects of medication on dopamine transporter imaging using [European journal of nuclear medicine and molecular imaging · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Francesco LanfranchiNuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa, Italy.
Dario ArnaldiIRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Alberto MiceliNuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa, Italy.
Pietro MattioliDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Francesca D'AmicoNuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa, Italy.
Stefano RaffaNuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa, Italy.
Maria Isabella DoneganiNuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa, Italy.
Silvia ChiolaNuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa, Italy.
Federico MassaDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Matteo PardiniIRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Tania Di RaimondoNuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa, Italy.
Gianmario SambucetiNuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa, Italy.
Matteo BaucknehtNuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa, Italy.
Flavio NobiliIRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Silvia MorbelliNuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa, Italy. silviadaniela.morbelli@hsanmartino.it.ORCID 0000-0002-7833-6095
Ospedale Policlinico San Martino · ITUniversity of Genoa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeA cut-off of -2 z-score for striatal or putaminal SBR has been to date arbitrarily used to define an abnormal DaT SPECT in patients with suspected neurodegenerative parkinsonism. We aimed to experimentally identify the most accurate z-score cut-offs for SBR of striatal and substriatal regions to independently discriminate PD and DLB, with respect to essential tremor (ET) and Alzheimer's disease (AD) respectively.

methodsTwo-hundred twenty-five patients undergoing DaT SPECT were enrolled (seventy-five de novo PD, eighty ET, fifty DLB, and twenty AD). Semiquantification was computed by means of Datquant® software which returns measures of striatal SBR and z-scores with respect to 118 healthy volunteers belonging to the Parkinson's Progression Markers Initiative (PPMI). ROC analysis was used to identify most accurate cut-offs for z-score for striatum and substriatal regions (clinical diagnosis at follow-up as gold standard).

resultsPosterior putamen of the most affected hemisphere (MAH) with a z-score cut-off of  - 1.27 demonstrated the highest accuracy to differentiate between PD and ET (sensitivity 0.97, specificity 0.94). The whole putamen (z-score cut-off  - 0.96) was the most accurate parameter to support the diagnosis of DLB (sensitivity 0.74, specificity 0.95). Putamen to caudate ratio was accurate to detect PD (especially in early stages) while not DLB patients.

conclusionWe experimentally demonstrated that different substriatal regions and cut-offs for z-score of SBR should be considered to support the diagnosis of either PD or DLB. The identified less conservative cut-offs showed higher sensitivity without a measurable reduction in specificity with respect to the arbitrary  - 2 z-score.

Indexed as

Alzheimer DiseaseLewy Body DiseaseParkinson DiseaseCorpus StriatumHumansTomography, Emission-Computed, Single-PhotonAlzheimer’s diseaseDaT SPECTDementia with Lewy bodiesEssential tremorParkinson diseaseSpecific binding ratio

Identifiers

PMID36471041
OpenAlexW4310776873

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.